These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 999044

  • 1. Effect of administration of a single dose of testosterone oenanthate on constituents of human seminal plasma and serum gonadotropins.
    Sheth AR, Jayatilak PG, Thakur AN, Mugatwala P, Pardanani DS.
    Andrologia; 1976; 8(3):259-64. PubMed ID: 999044
    [Abstract] [Full Text] [Related]

  • 2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 3. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [Abstract] [Full Text] [Related]

  • 4. Reversible inhibition of sperm production and gonadotrophin secretion in men following combined oral medroxyprogesterone acetate and percutaneous testosterone treatment.
    Soufir JC, Jouannet P, Marson J, Soumah A.
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):625-32. PubMed ID: 6221496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
    Reinberg A, Smolensky MH, Hallek M, Smith KD, Steinberger E.
    Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
    [Abstract] [Full Text] [Related]

  • 7. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [Abstract] [Full Text] [Related]

  • 8. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM, Baus S, Kliesch S, Keck C, Simoni M, Nieschlag E.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [Abstract] [Full Text] [Related]

  • 9. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [Abstract] [Full Text] [Related]

  • 10. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA, Yeung CH, Nieschlag E.
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [Abstract] [Full Text] [Related]

  • 11. Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men.
    Pangkahila W.
    Int J Androl; 1991 Aug; 14(4):248-56. PubMed ID: 1831798
    [Abstract] [Full Text] [Related]

  • 12. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [Abstract] [Full Text] [Related]

  • 13. Correlation between follicle-stimulating hormone, luteinizing hormone, prolactin, and testosterone with sperm cell concentration and motility.
    Vasquez JM, Ben-Nun I, Greenblatt RB, Mahesh VB, Keel BA.
    Obstet Gynecol; 1986 Jan; 67(1):86-90. PubMed ID: 3079622
    [Abstract] [Full Text] [Related]

  • 14. Effect of administration of a single dose of testosterone oenanthate on human serum and seminal plasma inhibin concentration.
    Hurkadli KS, Arbatti NJ, Mehta S, Sheth AR.
    Andrologia; 1983 Jan; 15(4):350-4. PubMed ID: 6416111
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropins (FSH and LH) and testosterone in human male serum and seminal plasma.
    Mladenović I, Genbacev O, Movsesijan M, Mićić S, Papić N.
    Acta Eur Fertil; 1993 Jan; 24(2):79-85. PubMed ID: 8171928
    [Abstract] [Full Text] [Related]

  • 16. Hormone levels in the reproductive system of normospermic men and patients with oligospermia and varicocele.
    Adamopoulos D, Lawrence DM, Vassilopoulos P, Kapolla N, Kontogeorgos L, McGarrigle HH.
    J Clin Endocrinol Metab; 1984 Sep; 59(3):447-52. PubMed ID: 6430947
    [Abstract] [Full Text] [Related]

  • 17. Plasma gonadotrophic hormones, testicular biopsy and seminal analysis in the men of infertile marriages.
    Pryor JP, Pugh RC, Cameron KM, Newton JR, Collins WP.
    Br J Urol; 1976 Sep; 48(7):709-17. PubMed ID: 1016846
    [Abstract] [Full Text] [Related]

  • 18. Patterns of hormones in the seminal plasma correlated with sperm count and motility.
    Mićić S, Dotlić R.
    Arch Androl; 1983 Aug; 11(1):9-12. PubMed ID: 6414397
    [Abstract] [Full Text] [Related]

  • 19. Endocrinology of male infertility.
    de Kretser DM.
    Br Med Bull; 1979 May; 35(2):187-92. PubMed ID: 387166
    [Abstract] [Full Text] [Related]

  • 20. Effect of long-term testosterone oenanthate administration on male reproductive function: clinical evaluation, serum FSH, LH, testosterone, and seminal fluid analyses in normal men.
    Mauss J, Börsch G, Bormacher K, Richter E, Leyendecker G, Nocke W.
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):373-84. PubMed ID: 1172906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.